Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled…

Overview of attention for article published in Lancet Infectious Diseases, June 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 7 news outlets
policy: 3 policy sources
twitter: 118 X users

reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 258 Mendeley

So far, Altmetric has seen 137 X posts from 118 X users, with an upper bound of 595,173 followers.

@PedroPfff @haveyoumetsara @curiosaeu4 @fernandaimamura + benefícios importantes em mulheres até 45 anos de idade e deveria ser indicada para essa população. Após essa idade a conduta deve ser individualizada pois a senescência imune diminui a resposta. …

@LeeKurtiss @sportsdoc2016 @dr_andrealove https://t.co/o4Sh3tLHnY

RT @Jose21maria34: @JuanGrvas Deja te humillo un rato https://t.co/xSuwKX7Uj4 Aquí a leer https://t.co/CfWWV1aej2 https://t.co/aOwItvrsox

@CeciMirador @JuanGrvas Deje de mentir que da pena https://t.co/GKEUC7rtxo

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 133 additional X posts.